Laser capture microdissection (LCM) is emerging as a premier technology with a point-and-shoot capability designed to rapidly isolate single cells or unique multicellular structures from complex ...

Laser microdissection instruments, such as the CellCut Plus ® and SmartCut Plus ® from Olympus, have proven to be excellent research and forensic tools. This is because they provide precise extraction ...

LMD allows researchers to target a specific cell—or even chromosome—and excise it from the cells that surround it on a slide, or in some cases, on a culture dish. 1 Researchers can use some LMD ...

Understanding genomic variation in the context of cancer is paramount to identifying disease drivers and informing personalized treatment for patients. Tumor heterogeneity presents a challenge in ...

This is a preview. Log in through your library . Abstract Iron ranks fourth in the sequence of abundance of the elements in the Earth's crust, but its low bio-availability often limits plant growth.

Correlation of allele-specific HLA loss of heterozygosity in patients with cancer with driver mutations. Baseline heterogeneity of myeloid and stroma cells to predict pCR, baseline lymph node (LN) ...

Cutting-edge dual-laser technology delivers power and precision in one device SEATTLE, Nov. 8, 2023 /PRNewswire/ -- Laxco is proud to announce the launch of the Accuva Cellect Laser Capture ...

Leica Microsystems is one of the market leaders in microscopy and scientific imaging. The company develops highly advanced instruments for the analysis of microstructures and nanostructures - ...

Microdissection is a method to isolate individual or group of cells from tissue sections. This results in preparation of samples of homogeneous cell types that allows performance of sensitive and ...

Neglecting tissue heterogeneity during the analysis of microRNA (miRNA) levels results in average signals from an unknown mixture of different cell types that are difficult to interpret. Here we ...

Therapeutic implications of phosphoproteomics in molecular cancer diagnostics. Utility of [18F]FDG PET/CT in predicting pathological complete response to neoadjuvant therapy in breast cancer: A ...